Stock comparison
Side-by-side financials for BGLC and DGX. Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
DGX is larger
Market cap data is available for the leading company in this comparison.
Market value leader
DGX
Latest market capitalization comparison.
Revenue leader
DGX
BGLC: $7.42M vs DGX: $11.04B.
Profit leader
DGX
BGLC: -$2.98M vs DGX: $992.00M.
Margin leader
DGX
BGLC: -40.2% vs DGX: 9.0% net margin.
| Metric | BGLC | DGX |
|---|---|---|
| Market cap | - | $22.96 B |
| US-listed rank | - | #576 |
| Revenue (latest FY) | $7.42M | $11.04B |
| Net income (latest FY) | -$2.98M | $992.00M |
| Net margin | -40.2% | 9.0% |
| P/E (trailing FY) | - | 23.1x |
| SEC filings | 140 | 2,372 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
In their latest fiscal years, BioNexus Gene Lab Corp reported $7.42M in revenue while QUEST DIAGNOSTICS INC reported $11.04B.
Full pages: BioNexus Gene Lab Corp and QUEST DIAGNOSTICS INC, or browse the full rankings.